• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腺病毒 F 蛋白作为肉毒杆菌 B 的递送载体。

Adenovirus F protein as a delivery vehicle for botulinum B.

机构信息

Montana State University, Bozeman, 59717-3610, USA.

出版信息

BMC Immunol. 2010 Jul 7;11:36. doi: 10.1186/1471-2172-11-36.

DOI:10.1186/1471-2172-11-36
PMID:20609248
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2912244/
Abstract

BACKGROUND

Immunization with recombinant carboxyl-terminal domain of the heavy chain (Hc domain) of botulinum neurotoxin (BoNT) stimulates protective immunity against native BoNT challenge. Most studies developing a botulism vaccine have focused on the whole Hc; however, since the principal protective epitopes are located within beta-trefoil domain (Hcbetatre), we hypothesize that immunization with the Hcbetatre domain is sufficient to confer protective immunity. In addition, enhancing its uptake subsequent to nasal delivery prompted development of an alternative vaccine strategy, and we hypothesize that the addition of targeting moiety adenovirus 2 fiber protein (Ad2F) may enhance such uptake during vaccination.

RESULTS

The Hcbetatre serotype B immunogen was genetically fused to Ad2F (Hcbetatre/B-Ad2F), and its immunogenicity was tested in mice. In combination with the mucosal adjuvant, cholera toxin (CT), enhanced mucosal IgA and serum IgG Ab titers were induced by nasal Hcbetatre-Ad2F relative to Hcbetatre alone; however, similar Ab titers were obtained upon intramuscular immunization. These BoNT/B-specific Abs induced by nasal immunization were generally supported in large part by Th2 cells, as opposed to Hcbetatre-immunized mice that showed more mixed Th1 and Th2 cells. Using a mouse neutralization assay, sera from animals immunized with Hcbetatre and Hcbetatre-Ad2F protected mice against 2.0 LD50.

CONCLUSION

These results demonstrate that Hcbetatre-based immunogens are highly immunogenic, especially when genetically fused to Ad2F, and Ad2F can be exploited as a vaccine delivery platform to the mucosa.

摘要

背景

用重组肉毒神经毒素(BoNT)重链羧基末端域(Hc 域)免疫可刺激针对天然 BoNT 攻击的保护性免疫。大多数开发肉毒杆菌毒素疫苗的研究都集中在整个 Hc 上;然而,由于主要的保护性表位位于β三叶形域(Hcbetatre)内,我们假设用 Hcbetatre 域免疫足以赋予保护性免疫。此外,增强其在鼻内给药后的摄取促使开发了另一种疫苗策略,我们假设添加靶向部分腺病毒 2 纤维蛋白(Ad2F)可能会在接种疫苗期间增强这种摄取。

结果

Hcbetatre 血清型 B 免疫原与 Ad2F (Hcbetatre/B-Ad2F) 遗传融合,并在小鼠中测试其免疫原性。与粘膜佐剂霍乱毒素(CT)结合,与单独的 Hcbetatre 相比,鼻内 Hcbetatre-Ad2F 诱导增强的粘膜 IgA 和血清 IgG Ab 滴度;然而,肌肉内免疫获得了类似的 Ab 滴度。这些由鼻内免疫引起的 BoNT/B 特异性 Ab 主要由 Th2 细胞支持,而不是由 Hcbetatre 免疫的小鼠产生的 Th1 和 Th2 细胞混合支持。使用小鼠中和测定法,用 Hcbetatre 和 Hcbetatre-Ad2F 免疫的动物的血清可保护小鼠免受 2.0 LD50 的攻击。

结论

这些结果表明,基于 Hcbetatre 的免疫原具有高度的免疫原性,特别是当与 Ad2F 遗传融合时,并且可以利用 Ad2F 作为粘膜疫苗的传递平台。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9556/2912244/485ec4c9aaaa/1471-2172-11-36-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9556/2912244/cc010a3862ff/1471-2172-11-36-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9556/2912244/c3a1200ca8e1/1471-2172-11-36-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9556/2912244/7b7f9b02eebd/1471-2172-11-36-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9556/2912244/61e30e9cd202/1471-2172-11-36-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9556/2912244/f11115f51906/1471-2172-11-36-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9556/2912244/485ec4c9aaaa/1471-2172-11-36-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9556/2912244/cc010a3862ff/1471-2172-11-36-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9556/2912244/c3a1200ca8e1/1471-2172-11-36-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9556/2912244/7b7f9b02eebd/1471-2172-11-36-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9556/2912244/61e30e9cd202/1471-2172-11-36-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9556/2912244/f11115f51906/1471-2172-11-36-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9556/2912244/485ec4c9aaaa/1471-2172-11-36-6.jpg

相似文献

1
Adenovirus F protein as a delivery vehicle for botulinum B.腺病毒 F 蛋白作为肉毒杆菌 B 的递送载体。
BMC Immunol. 2010 Jul 7;11:36. doi: 10.1186/1471-2172-11-36.
2
Mucosal vaccine targeting improves onset of mucosal and systemic immunity to botulinum neurotoxin A.靶向黏膜疫苗可改善对肉毒杆菌神经毒素A的黏膜和全身免疫反应的起始。
J Immunol. 2006 Oct 15;177(8):5524-32. doi: 10.4049/jimmunol.177.8.5524.
3
Sublingual immunization with adenovirus F protein-based vaccines stimulates protective immunity against botulinum neurotoxin A intoxication.舌下免疫接种基于腺病毒 F 蛋白的疫苗可刺激针对肉毒神经毒素 A 中毒的保护性免疫。
Int Immunol. 2012 Feb;24(2):117-28. doi: 10.1093/intimm/dxr106. Epub 2011 Dec 29.
4
Mucosal targeting of a BoNT/A subunit vaccine adjuvanted with a mast cell activator enhances induction of BoNT/A neutralizing antibodies in rabbits.黏膜靶向的 BoNT/A 亚单位疫苗佐剂与肥大细胞激活剂增强了兔体内 BoNT/A 中和抗体的诱导。
PLoS One. 2011 Jan 27;6(1):e16532. doi: 10.1371/journal.pone.0016532.
5
Enhancing toxin-based vaccines against botulism.增强基于毒素的肉毒梭菌疫苗。
Vaccine. 2018 Feb 1;36(6):827-832. doi: 10.1016/j.vaccine.2017.12.064. Epub 2018 Jan 4.
6
An adenoviral vector-based mucosal vaccine is effective in protection against botulism.基于腺病毒载体的黏膜疫苗能有效预防肉毒中毒。
Gene Ther. 2009 Mar;16(3):367-75. doi: 10.1038/gt.2008.181. Epub 2009 Jan 8.
7
Expression of Hc fragment from Clostridium botulinum neurotoxin serotype B in Escherichia coli and its use as a good immunogen.肉毒杆菌神经毒素B型Hc片段在大肠杆菌中的表达及其作为良好免疫原的应用。
Hum Vaccin. 2010 Jun;6(6):462-6. doi: 10.4161/hv.6.6.11709. Epub 2010 Jun 1.
8
Novel platform for engineering stable and effective vaccines against botulinum neurotoxins A, B and E.新型平台可用于研发针对肉毒神经毒素 A、B 和 E 的稳定且有效的疫苗。
Front Immunol. 2024 Sep 9;15:1469919. doi: 10.3389/fimmu.2024.1469919. eCollection 2024.
9
Protective immunity against botulism provided by a single dose vaccination with an adenovirus-vectored vaccine.单剂量腺病毒载体疫苗接种提供的针对肉毒中毒的保护性免疫。
Vaccine. 2007 Oct 23;25(43):7540-8. doi: 10.1016/j.vaccine.2007.08.035. Epub 2007 Sep 5.
10
Evaluation of a recombinant Hc of Clostridium botulinum neurotoxin serotype F as an effective subunit vaccine.评估肉毒梭菌神经毒素F型重组重链作为一种有效亚单位疫苗的效果。
Clin Vaccine Immunol. 2008 Dec;15(12):1819-23. doi: 10.1128/CVI.00239-08. Epub 2008 Oct 8.

引用本文的文献

1
Optimized Mucosal Modified Vaccinia Virus Ankara Prime/Soluble gp120 Boost HIV Vaccination Regimen Induces Antibody Responses Similar to Those of an Intramuscular Regimen.优化黏膜组织修饰安卡拉痘苗病毒初免/可溶性 gp120 加强型 HIV 疫苗接种方案诱导的抗体应答类似于肌肉内接种方案。
J Virol. 2019 Jun 28;93(14). doi: 10.1128/JVI.00475-19. Print 2019 Jul 15.
2
Enhancing toxin-based vaccines against botulism.增强基于毒素的肉毒梭菌疫苗。
Vaccine. 2018 Feb 1;36(6):827-832. doi: 10.1016/j.vaccine.2017.12.064. Epub 2018 Jan 4.
3
Sublingual immunization with adenovirus F protein-based vaccines stimulates protective immunity against botulinum neurotoxin A intoxication.

本文引用的文献

1
An adenoviral vector-based mucosal vaccine is effective in protection against botulism.基于腺病毒载体的黏膜疫苗能有效预防肉毒中毒。
Gene Ther. 2009 Mar;16(3):367-75. doi: 10.1038/gt.2008.181. Epub 2009 Jan 8.
2
Botulinum neurotoxin vaccines: past, present, and future.肉毒杆菌神经毒素疫苗:过去、现在与未来。
Crit Rev Immunol. 2007;27(4):303-18. doi: 10.1615/critrevimmunol.v27.i4.20.
3
Subunit vaccine against the seven serotypes of botulism.针对肉毒中毒七种血清型的亚单位疫苗。
舌下免疫接种基于腺病毒 F 蛋白的疫苗可刺激针对肉毒神经毒素 A 中毒的保护性免疫。
Int Immunol. 2012 Feb;24(2):117-28. doi: 10.1093/intimm/dxr106. Epub 2011 Dec 29.
Infect Immun. 2008 Mar;76(3):1314-8. doi: 10.1128/IAI.01025-07. Epub 2007 Dec 10.
4
Enhanced immune responses using plasmid DNA replicon vaccine encoding the Hc domain of Clostridium botulinum neurotoxin serotype A.使用编码A型肉毒杆菌神经毒素Hc结构域的质粒DNA复制子疫苗增强免疫反应。
Vaccine. 2007 Dec 17;25(52):8843-50. doi: 10.1016/j.vaccine.2007.10.016. Epub 2007 Oct 25.
5
Recombinant holotoxoid vaccine against botulism.抗肉毒中毒重组类毒素疫苗。
Infect Immun. 2008 Jan;76(1):437-42. doi: 10.1128/IAI.00843-07. Epub 2007 Oct 29.
6
Trivalent vaccine against botulinum toxin serotypes A, B, and E that can be administered by the mucosal route.可通过黏膜途径给药的抗A、B和E型肉毒杆菌毒素的三价疫苗。
Infect Immun. 2007 Jun;75(6):3043-54. doi: 10.1128/IAI.01893-06. Epub 2007 Mar 19.
7
Mucosal vaccine targeting improves onset of mucosal and systemic immunity to botulinum neurotoxin A.靶向黏膜疫苗可改善对肉毒杆菌神经毒素A的黏膜和全身免疫反应的起始。
J Immunol. 2006 Oct 15;177(8):5524-32. doi: 10.4049/jimmunol.177.8.5524.
8
Botulism: the many faces of botulinum toxin and its potential for bioterrorism.肉毒中毒:肉毒杆菌毒素的多种表现形式及其在生物恐怖主义中的潜在威胁。
Infect Dis Clin North Am. 2006 Jun;20(2):313-27, ix. doi: 10.1016/j.idc.2006.02.003.
9
Recombinant C fragment of botulinum neurotoxin B serotype (rBoNTB (HC)) immune response and protection in the rhesus monkey.肉毒杆菌神经毒素B型重组C片段(rBoNTB(HC))在恒河猴体内的免疫反应及保护作用
Toxicon. 2006 Jun 15;47(8):877-84. doi: 10.1016/j.toxicon.2006.02.013. Epub 2006 Mar 24.
10
Characterization of the antibody response to the receptor binding domain of botulinum neurotoxin serotypes A and E.对A型和E型肉毒杆菌神经毒素受体结合域抗体反应的表征
Infect Immun. 2005 Oct;73(10):6998-7005. doi: 10.1128/IAI.73.10.6998-7005.2005.